设计用于癌症基因治疗的细胞P450酶
Saskya E Carrera-Pacheco1, Alexander Mueller1, Juan A Puente-Pineda1
1Centro de Investigación Biomédica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
工程化P450 (CYP) 酶在癌症基因治疗中提供了一种有前途的方法. 基因导向酶原药疗法 (GDEPT) 使用这些修饰的酶来激活癌细胞内的化疗药物,从而提高治疗效率.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 癌症对全球健康和经济构成重大挑战,每年有数百万人死亡.
- 基因治疗的进步正在改变癌症治疗策略.
- 基因导向酶前药疗法 (GDEPT) 是针对癌症治疗的新兴方法.
研究的目的:
- 为增强癌症基因疗法编译基因修改的P450 (CYP) 酶.
- 审查在GDEPT中工程化CYP酶的潜力.
- 讨论基于CYP的GDEPT的挑战和未来方向.
主要方法:
- 使用合理设计,定向进化和遗传学方法对CYP酶进行基因工程.
- 临床前和临床试验的审查,涉及对GDEPT进行工程化CYP酶.
- 旨在提高治疗基因效率的基因修饰的汇编.
主要成果:
- 工程化CYP酶可以被定制为有效地生物激活各种化疗前药物.
- 使用工程化CYP酶的GDEPT在临床前和临床环境中显示出前景.
- 基因修饰增强CYP酶活性,以向癌细胞的消除.
结论:
- 工程化CYP酶代表了在癌症基因治疗中推进GDEPT的强大工具.
- 优化的CYP酶可以改善前药物转化,增加治疗疗效,并最大限度地减少化疗副作用.
- 对挑战和局限性的进一步研究将指导基于CYP的GDEPT的未来发展.
更多相关视频
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Gene Therapy
